


A recent major review from the U.K. may change that, though. The reviewers emphatically stated that inflammatory cytokines are elevated in ME/CFS, and challenged the researchers to do the kind of big and comprehensive studies – which could lead to readily available treatments.
Find out more in this Simmaron Research Foundation sponsored post:


